|
SF3B2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.785200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.420200E-01 |
| Normal-vs-Stage2 |
6.476800E-01 |
| Normal-vs-Stage3 |
4.569400E-01 |
| Normal-vs-Stage4 |
8.780800E-01 |
| Stage1-vs-Stage2 |
8.560200E-01 |
| Stage1-vs-Stage3 |
6.623200E-01 |
| Stage1-vs-Stage4 |
8.397800E-01 |
| Stage2-vs-Stage3 |
9.017400E-01 |
| Stage2-vs-Stage4 |
7.629200E-01 |
| Stage3-vs-Stage4 |
6.281800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.541200E-01 |
| Normal-vs-AfricanAmerican |
1.671380E-01 |
| Normal-vs-Asian |
6.409400E-01 |
| Caucasian-vs-AfricanAmerican |
6.347700E-02 |
| Caucasian-vs-Asian |
4.018800E-01 |
| AfricanAmerican-vs-Asian |
2.748200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.321200E-01 |
| Normal-vs-Female |
6.957600E-01 |
| Male-vs-Female |
5.427600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.662800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.997800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.469400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.817600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.360800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.443600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.722640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.537380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.091000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.911810E-01 |
| Classical-VS-Follicular |
1.84585999999376E-05 |
| Classical-VS-Other |
1.577600E-01 |
| Classical-VS-Normal |
4.083200E-01 |
| Tall-VS-Follicular |
4.477900E-02 |
| Tall-VS-Other |
4.779000E-01 |
| Tall-VS-Normal |
5.247800E-01 |
| Follicular-VS-Other |
7.736000E-01 |
| Follicular-VS-Normal |
3.161300E-03 |
| Other-VS-Normal |
4.501600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.640400E-01 |
| Normal-vs-N1 |
1.216470E-02 |
| N0-vs-N1 |
7.186200E-02 |
|
|
